Filing Details
- Accession Number:
- 0000899243-22-000473
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-04 16:05:24
- Reporting Period:
- 2021-12-31
- Accepted Time:
- 2022-01-04 16:05:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1274792 | Merrimack Pharmaceuticals Inc | MACK | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1225960 | T Russell Ray | C/O Merrimack Pharmaceuticals, Inc. One Broadway 14Th Floor Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-12-31 | 1,000 | $3.84 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
